Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Artificial intelligence-based drug repositioning method and its application for alzheimer's disease

International Conference on Alzheimer and Dementia
July 12, 2021 | Webinar

Shingo Tsuji

The University of Tokyo, Japan

Scientific Tracks Abstracts: ipjnn


In this study, we developed a deep learning-based computational framework that can identify potential novel therapeutic targets. Our method utilizes protein-protein interaction networks to prioritize the targets. The key technology of the method is to extract low-dimensional representations (latent features) of high-dimensional protein-protein interaction data. The framework also includes state-of-the-art machine learning techniques to infer potential drug target genes. We applied our method to obtain novel putative target genes for Alzheimer's disease and successfully identified key genes that may serve as novel therapeutic targets (e.g., DLG4, EGFR, RAC1, SYK, PTK2B, SOCS1). Furthermore, based on these putative targets, we could infer repositionable candidate-compounds for the disease (e.g., Tamoxifen, Bosutinib, and Dasatinib). Our deep learning-based computational framework could be a powerful tool to efficiently prioritize new therapeutic targets and enhance the drug repositioning strategy.